Grateful for @sophiahlg's mentorship in improving global #breastcancer care. Passionate about making a difference in patients' lives! Sylvester Comprehensive Cancer Center

Addressing disparities in #ClinicalTrials enrolment in #lungcancer among minority populations is crucial. Our study sheds light on the experience at a safety net hospital, emphasizing the need for inclusivity. #HealthEquity Harshitha Dudipala, MD Umit Tapan Sylvester Comprehensive Cancer Center twitter.com/hersheydudipal…

Excited to present this evening my Lymphoma Research Foundation clinical investigator career development award in R/R follicular lymphoma now transitioning to a multicenter study. Sylvester Comprehensive Cancer Center Miller Medicine #ASH23

Amazing Celebration for Sylvester Comprehensive Cancer Center and I have proof these 2 were back to work early this morning! Jash Datta, MD Stephen D. Nimer, MD

Excellent work Shria Kumar!

Interesting surprise from the #SABCS23 online program: final iDFS and updated OS analysis from KATHERINE to be presented at the congress. Important data to inform, and hopefully reinforce, a standard treatment paradigm.

So proud of my dear friend Antonio Ocejo ! Memorial Sloan Kettering Cancer Center is so lucky to have you!!

This is an exciting day for desmoid tumor patients! The first-ever medical therapy approved for desmoid tumors.

10 days to #SABCS23 , 10 abstracts to keep an eye on. They include practice changing studies, highly awaited updates, important biomarker analyses, & RWD, among others. Not an easy selection: many more impactful studies will be presented. Full program here: sabcs.org/FullProgram

Shout out the great and very humble University of Miami Internal Medicine Residency #HengTanMD for getting this review paper to the finish line. Check it out for everything you always wanted to know about HRD in #PancSM and were afraid to ask! Sylvester Comprehensive Cancer Center #WageHope jgo.amegroups.org/article/view/7…

Just out at JCO Precision Oncology:
we analyzed nearly
30K breast cancers and reported the specific frequencies of alterations in the HRD pathways. Also showed that somatic BRCA and germline PALB2 derive similar benefit to gBRCA Mayo Clinic BIDMC Dana-Farber ascopubs.org/doi/abs/10.120…

Published in Blood Journal today, our approach to secondary CNS involvement by aggressive lymphomas

Here is a free access link authors.elsevier.com/a/1i8Pv1UYwjRKH

ashpublications.org/blood/article-…

Grateful to Sylvester Comprehensive Cancer Center and Stephen D. Nimer, MD for the Outstanding Early-Researcher Award! 🏆 Working in such a supportive environment is a true blessing. Special thanks to Laurie Glimcher MD for an inspiring Zubrod Memorial Lecture. Excited for what's to come!

Capivasertib is now approved in combo with fulvestrant for pts with pretreated ER+/HER2- MBC whose tumor has an alteration in PIK3CA, AKT1 or PTEN (approx 40%).

More important than ever to perform NGS/ctDNA to select the best 2L treatment after CDK4/6i.

fda.gov/drugs/resource…

Stop by our Sylvester Comprehensive Cancer Center and collaborative posters today at 5:30pm #CTOS2023 #BetterTogether Gina Z. D'Amato, MD. Emily Jonczak, MD Steve Bialick, DO Priscila Barreto Coelho, MD Neha Goel MD, MPH, FACS Brandon Rose, MD, MPH Philippos Apolinario Costa, MD

For LMIC I think the most efficient and effective way would be for a generous lab or company to offer to do this centrally, at no cost to patient. And education about why mutation testing relevant The Max Foundation OOO Foundation Medicine Caris Life Sciences Jon Trent, MD, PhD

Love seeing the important work on racial disparities by Priscila Barreto Coelho, MD from Sylvester Comprehensive Cancer Center highlighted!!!

Great presentation by Priscila Barreto Coelho, MD on racial and ethnic disparities in patients diagnosed with/ GIST #sarcoma #CTOS2023 Jon Trent, MD, PhD

@CTOS #CTOS23 Thursday, November 2, 9-10AM

Priscila Barreto Coelho, MD Steve Bialick, DO Gina Z. D'Amato, MD. Emily Jonczak, MD Brandon Rose, MD, MPH Sylvester Comprehensive Cancer Center #Sarcoma #GIST #CTOS2023